Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
API
0
FDF
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. (glycolato-o,o')diammineplatinum Ii
2. 254-s
3. Cgdp-ii
4. Cis-diammine(glycolato)platinum Ii
5. Nedaplatin
6. Nsc 375101d
7. Nsc-375101d
1. Nedaplatin
2. 95734-82-0
3. Nsc 375101d
4. Azane;2-hydroxyacetic Acid;platinum
5. C2h8n2o3pt
6. C2-h8-n2-o3-pt
7. Nsc-375101d
8. Cis-diammine(glycolato)platinum(ii)
9. (glycolato-o,o')diammineplatinum(ii)
10. Hms2089p16
11. Akos025311233
Molecular Weight | 305.20 g/mol |
---|---|
Molecular Formula | C2H10N2O3Pt |
Hydrogen Bond Donor Count | 4 |
Hydrogen Bond Acceptor Count | 5 |
Rotatable Bond Count | 0 |
Exact Mass | g/mol |
Monoisotopic Mass | g/mol |
Topological Polar Surface Area | 59.5 |
Heavy Atom Count | 8 |
Formal Charge | 0 |
Complexity | 44.1 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 4 |
Antineoplastic Agents
Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?